mt logoMyToken
ETH Gas
日本語

Moderna Stock Doubles, Adding $26.4 Billion After Cancer Vaccine Meets Both Phase 3 Goals

収集collect
シェアshare

Moderna Stock Doubles, Adding $26.4 Billion After Cancer Vaccine Meets Both Phase 3 Goals

Moderna stock more than doubled at its premarket peak Wednesday after the company’s personalized mRNA cancer treatment, developed with Merck, succeeded in a pivotal Phase 3 melanoma trial. MRNA rose by approximately 105% from Tuesday’s $62.96 closing price, reaching an estimated peak near $129.07.

Visit Website

免責事項:この記事の著作権は元の作者に帰属し、MyTokenを表すものではありません(www.mytokencap.com)ご意見・ご感想・内容、著作権等ご不明な点がございましたらお問い合わせください。
MyTokenについて:https://www.mytokencap.com/aboutusこの記事へのリンク:https://www.mytokencap.com/news/593561.html
community_x_prefix
X(https://x.com/MyTokencap)
community_tg_prefixcommunity_tg_name
https://t.me/mytokenGroup
関連読書